U.S. markets closed

Esperion Therapeutics: 1Q Earnings Snapshot

ANN ARBOR, Mich. (AP) _ Esperion Therapeutics Inc. (ESPR) on Wednesday reported a first-quarter loss of $78.2 million, after reporting a profit in the same period a year earlier.

On a per-share basis, the Ann Arbor, Michigan-based company said it had a loss of $2.84.

The results beat Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of $3.14 per share.

The biopharmaceutical company posted revenue of $1.8 million in the period.

Esperion Therapeutics shares have decreased 32% since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $40.60, a decline of 16% in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ESPR at https://www.zacks.com/ap/ESPR